Medicines labeled for the same conditions
Alternatives to enalaprilat
4 other medicines are given the same way (intravenous) and in the same FDA class as enalaprilat or labeled mainly for the same use (high blood pressure); the others include 3 beta-adrenergic blockers and 1 dihydropyridine calcium channel blocker (FDA labels read October 8, 2026).
Which medicines are labeled for the same conditions as enalaprilat?
High blood pressure lists all 88 medicines labeled for it, by any route. Each row shows the conditions both labels name. They are listed as public records, not as substitutes: whether one can replace another depends on the person and is a prescriber's decision.
| Medicine and FDA class | Shared indication | Generic labelers (intravenous) | Pharmacy cost | Boxed warning | Shortage |
|---|---|---|---|---|---|
| Enalaprilatangiotensin converting enzyme inhibitor | this medicine | 3 labelers | n/a | Yes | No current entry |
| Esmololbeta-adrenergic blocker | High blood pressure | 12 labelers | n/a | No | No current entry |
| Nicardipinedihydropyridine calcium channel blocker | High blood pressure | 16 labelers | n/a | No | No current entry |
| Labetalolbeta-adrenergic blocker | High blood pressure | 15 labelers | $0.185 per mL 100 mg/20 mL vial | No | No current entry |
| Metoprololbeta-adrenergic blocker | High blood pressure | 14 labelers | n/a | No | A presentation being discontinued |
Source: FDA drug labels (indications) via openFDA; FDA NDC Directory; CMS NADAC of October 7, 2026; FDA Drug Shortage Database (FDA files October 8, 2026)
What do pharmacies pay for each?
The headline NADAC price per unit of each medicine's most widely listed form; strengths differ, so compare like with like on each record.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price
What next?
- Enalaprilat: the full record
- label, generics, price, shortages, recalls